Team reports major breakthrough in understanding Alzheimer's disease

by Trinity College DublinA human donor Alzheimer's disease brain tissue stained with an agent called 'congo-red', which allows for the visualization of amyloid-beta plaques (red) in t

Updated on: February 26,2024

Team reports major breakthrough in understanding Alzheimer's disease

by Trinity College DublinA human donor Alzheimer's disease brain tissue stained with an agent called 'congo-red', which allows for the visualization of amyloid-beta plaques (red) in t

Updated on:February 26,2024

Study hints at ways to generate new neurons in old brains

byStanford University Medical CenterCredit: CC0 Public DomainMost neurons in the human brain last a lifetime, and for good reason. Intricate, long-term information is preserved in the complex st

Updated on: October 18,2024

Study hints at ways to generate new neurons in old brains

byStanford University Medical CenterCredit: CC0 Public DomainMost neurons in the human brain last a lifetime, and for good reason. Intricate, long-term information is preserved in the complex st

Updated on:October 18,2024

Vitamin C deficiency and mitochondrial dysfunction in Alzheimer's disease

by Gabrielle Rushing,Vanderbilt UniversityEarly clinical features of sporadic Alzheimer's disease include alterations in mitochondrial functionthat appearprior to classical featu

Updated on: March 07,2024

Vitamin C deficiency and mitochondrial dysfunction in Alzheimer's disease

by Gabrielle Rushing,Vanderbilt UniversityEarly clinical features of sporadic Alzheimer's disease include alterations in mitochondrial functionthat appearprior to classical featu

Updated on:March 07,2024

HBOT showed improvement in Alzheimer's disease

by Louisiana State UniversityCredit: Louisiana State UniversityDr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward

Updated on: March 30,2024

HBOT showed improvement in Alzheimer's disease

by Louisiana State UniversityCredit: Louisiana State UniversityDr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward

Updated on:March 30,2024

Problems finding your way around may be earliest sign of Alzheimer's disease

by Gerry Everding,Washington University in St. LouisA bird's-eye view of a virtual maze layout used in a study of how cognitive mapping and wayfinding skills are compromised in early stages

Updated on: February 28,2024

Problems finding your way around may be earliest sign of Alzheimer's disease

by Gerry Everding,Washington University in St. LouisA bird's-eye view of a virtual maze layout used in a study of how cognitive mapping and wayfinding skills are compromised in early stages

Updated on:February 28,2024

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a

Updated on: March 07,2024

Long-term use of opioid patches common among persons with Alzheimer's disease

by University of Eastern FinlandApproximately seven per cent of persons with Alzheimer's disease use strong pain medicines, opioids, for non-cancer pain for a period longer than six months, a

Updated on:March 07,2024

New synapse type discovered through spatial proteomics

by Tamara Bäßler,Max Planck SocietyNeuronal atlas with 30 different protein types in spatial resolution, visualized with the new SUM-PAINT method. The detailed images illustrate the extremely hi

Updated on: March 30,2024

New synapse type discovered through spatial proteomics

by Tamara Bäßler,Max Planck SocietyNeuronal atlas with 30 different protein types in spatial resolution, visualized with the new SUM-PAINT method. The detailed images illustrate the extremely hi

Updated on:March 30,2024

New test could predict dementia risk during routine GP visits

by BioMed CentralDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.It may be possible to assess the risk of developing dementia by analyzing informati

Updated on: February 27,2024

New test could predict dementia risk during routine GP visits

by BioMed CentralDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.It may be possible to assess the risk of developing dementia by analyzing informati

Updated on:February 27,2024

Study says Alzheimer's plaques can also affect the brain's blood vessels

by Bob Shepard,University of Alabama at Birmingham3-D microscope image of blood vessels (in red) with surrounding vascular amyloid plaques (in green). Credit: Ian KimbroughAmyloid beta, the plaq

Updated on: February 27,2024

Study says Alzheimer's plaques can also affect the brain's blood vessels

by Bob Shepard,University of Alabama at Birmingham3-D microscope image of blood vessels (in red) with surrounding vascular amyloid plaques (in green). Credit: Ian KimbroughAmyloid beta, the plaq

Updated on:February 27,2024

Experimental drug targeting Alzheimer's disease shows anti-aging effects

by Salk InstituteAs mice age, those treated with J147 (right) showed improved physiology, memory and appearance that more closely resembled younger mice. Credit: Salk Institute for Biological Stu

Updated on: February 27,2024

Experimental drug targeting Alzheimer's disease shows anti-aging effects

by Salk InstituteAs mice age, those treated with J147 (right) showed improved physiology, memory and appearance that more closely resembled younger mice. Credit: Salk Institute for Biological Stu

Updated on:February 27,2024

Allopurinol may cut risk for neurodegenerative diseases

by Elana GotkineXanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 inPLOS ONE.Yizhe Song, from the Washingto

Updated on: February 05,2024

Allopurinol may cut risk for neurodegenerative diseases

by Elana GotkineXanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 inPLOS ONE.Yizhe Song, from the Washingto

Updated on:February 05,2024

Modulation of brain cholesterol: A new line of research in Alzheimer's disease treatment?

by Institut National de la Sante et de la Recherche MedicaleFluorescent labelling of the Tau protein in a hNT human cell. Credit: ©Inserm/U837We have known for some years that Alzheimer&#39

Updated on: February 26,2024

Modulation of brain cholesterol: A new line of research in Alzheimer's disease treatment?

by Institut National de la Sante et de la Recherche MedicaleFluorescent labelling of the Tau protein in a hNT human cell. Credit: ©Inserm/U837We have known for some years that Alzheimer&#39

Updated on:February 26,2024